Publications by authors named "Koen Jacobs"

Claim this Profile
V
Variant-specific BCR::ABL1 quantification discrepancy in chronic myeloid leukemia.
Koen Jacobs, Alena Moerman, Karl Vandepoele, Tim Van den Abeele, Katrien De Mulder

Int J Lab Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of Somatic Variant Classifications in Solid and Haematological Tumours by a Two-Level Approach of Biological and Clinical Classes: An Initiative of the Belgian ComPerMed Expert Panel.
Guy Froyen, Marie Le Mercier, Els Lierman, Karl Vandepoele, Friedel Nollet, Koen Jacobs

Cancers (Basel)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR in melanoma: clinical significance and potential therapeutic target.
Barbara Boone, Koen Jacobs, Liesbeth Ferdinande, Jasmien Taildeman, Jo Lambert

J Cutan Pathol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P-cadherin expression reduces melanoma growth, invasion, and responsiveness to growth factors in nude mice.
Koen Jacobs, Lynn Feys, Barbara Vanhoecke, Veerle Van Marck, Marc Bracke

Eur J Cancer Prev· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P-cadherin in adhesion and invasion: opposite roles in colon and bladder carcinoma.
Veerle Van Marck, Christophe Stove, Koen Jacobs, Gert Van den Eynden, Marc Bracke

Int J Cancer· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P-cadherin counteracts myosin II-B function: implications in melanoma progression.
Koen Jacobs, Mireille Van Gele, Ramses Forsyth, Lieve Brochez, Barbara Vanhoecke

Mol Cancer· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis